Cross-National Key Performance Measures of the Quality of Acute Stroke Care in Western Europe
Autor: | Bo, Norrving, Benjamin D, Bray, Kjell, Asplund, Peter, Heuschmann, Peter, Langhorne, Anthony G, Rudd, Markus, Wagner, Silke, Wiedmann, Charles D A, Wolfe, Miquel, Gallofré |
---|---|
Rok vydání: | 2015 |
Předmět: |
medicine.medical_specialty
Consensus media_common.quotation_subject Brain Ischemia Time-to-Treatment Cohort Studies Health care medicine Secondary Prevention Humans Quality (business) Thrombolytic Therapy Prospective Studies Registries Stroke Antihypertensive Agents media_common Acute stroke Hypolipidemic Agents Quality Indicators Health Care Quality of Health Care Advanced and Specialized Nursing business.industry Endovascular Procedures Anticoagulants Arrhythmias Cardiac medicine.disease Europe Survival Rate Western europe Family medicine Platelet aggregation inhibitor Neurology (clinical) Medical emergency Cardiology and Cardiovascular Medicine business Platelet Aggregation Inhibitors Cross national Cohort study |
Zdroj: | Stroke. 46(10) |
ISSN: | 1524-4628 |
Popis: | Background and Purpose— There are no agreed measures of stroke care quality that enable the standardized comparison of stroke care between countries. We aimed to develop a set of measures of quality of acute stroke care involving stroke quality registers in Western Europe. Methods— A multinational working group identified 6 regional or national stroke quality registers in Europe and reviewed their data sets, performance measures, and the method by which these had been developed. Measures used in the registers were presented for discussion to a consensus group of representatives from the quality registers identified, as well as other stroke experts, and the final set of common performance measures was agreed through majority consensus. Results— Thirty final performance measures were agreed by the European consensus group, encompassing the domains of coordination of care (stroke unit–based care), diagnosis (brain imaging, vascular imaging, cardiac arrhythmia detection, and therapy assessment), preservation of neural tissue (thrombolytic therapy and door-to-needle time), prevention of complications (dysphagia screening), initiation of secondary prevention (antiplatelet, anticoagulation, lipid lowering, blood pressure lowering, carotid surgery, time from vascular imaging to carotid surgery, and smoking cessation), survival (90-day poststroke mortality), and functional outcomes (90-day modified Rankin Scale). Conclusions— On the basis of experience of quality registers in Europe, we have proposed a common set of performance measures that will facilitate the international comparison of acute stroke care quality. |
Databáze: | OpenAIRE |
Externí odkaz: |